Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Vanishing of ruptured adrenal mass with takotsubo cardiomyopathy.

Takeshita Y, Teramura C, Takamura T.

Endocr J. 2018 Sep 8. doi: 10.1507/endocrj.EJ18-0119. [Epub ahead of print]

2.

Effects of metformin and alogliptin on body composition in people with type 2 diabetes.

Takeshita Y, Kita Y, Kato KI, Kanamori T, Misu H, Kaneko S, Takamura T.

J Diabetes Investig. 2018 Aug 29. doi: 10.1111/jdi.12920. [Epub ahead of print]

3.

Expected limits on the ocean acidification buffering potential of a temperate seagrass meadow.

Koweek DA, Zimmerman RC, Hewett KM, Gaylord B, Giddings SN, Nickols KJ, Ruesink JL, Stachowicz JJ, Takeshita Y, Caldeira K.

Ecol Appl. 2018 Jul 31. doi: 10.1002/eap.1771. [Epub ahead of print]

PMID:
30063809
4.

Spectral-Spatial Differentiation of Brain Activity During Mental Imagery of Improvisational Music Performance Using MEG.

Boasen J, Takeshita Y, Kuriki S, Yokosawa K.

Front Hum Neurosci. 2018 Apr 24;12:156. doi: 10.3389/fnhum.2018.00156. eCollection 2018.

5.

Does intrawound vancomycin powder reduce surgical site infection after posterior instrumented spinal surgery? A propensity score-matched analysis.

Horii C, Yamazaki T, Oka H, Azuma S, Ogihara S, Okazaki R, Kawamura N, Takano Y, Morii J, Takeshita Y, Maruyama T, Yamakawa K, Murakami M, Oshima Y, Tanaka S.

Spine J. 2018 Apr 26. pii: S1529-9430(18)30188-8. doi: 10.1016/j.spinee.2018.04.015. [Epub ahead of print]

PMID:
29705336
6.

Fingolimod promotes blood-nerve barrier properties in vitro.

Nishihara H, Maeda T, Sano Y, Ueno M, Okamoto N, Takeshita Y, Shimizu F, Koga M, Kanda T.

Brain Behav. 2018 Mar 25;8(4):e00924. doi: 10.1002/brb3.924. eCollection 2018 Apr.

7.

Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study.

Shima KR, Ota T, Kato KI, Takeshita Y, Misu H, Kaneko S, Takamura T.

BMJ Open Diabetes Res Care. 2018 Mar 17;6(1):e000469. doi: 10.1136/bmjdrc-2017-000469. eCollection 2018.

8.

Carbon dioxide addition to coral reef waters suppresses net community calcification.

Albright R, Takeshita Y, Koweek DA, Ninokawa A, Wolfe K, Rivlin T, Nebuchina Y, Young J, Caldeira K.

Nature. 2018 Mar 22;555(7697):516-519. doi: 10.1038/nature25968. Epub 2018 Mar 14.

PMID:
29539634
9.

Fibrinolytic abnormality associated with progression of pediatric solid tumor.

Ishihara T, Nogami K, Takeshita Y, Ochi S, Shima M.

Pediatr Int. 2018 Jun;60(6):540-546. doi: 10.1111/ped.13546. Epub 2018 May 16.

PMID:
29505702
10.

A Case of Schwannoma of the Submandibular Region.

Bamgbose BO, Sato A, Yanagi Y, Hisatomi M, Takeshita Y, Sugianto I, Asaumi J.

Open Dent J. 2018 Jan 29;12:12-18. doi: 10.2174/1874210601812010012. eCollection 2018.

11.

Prediction of detectability of the mandibular canal by quantitative image quality evaluation using cone beam CT.

Takeshita Y, Shimizu M, Jasa GR, Weerawanich W, Okamura K, Yoshida S, Tokumori K, Asaumi J, Yoshiura K.

Dentomaxillofac Radiol. 2018 May;47(4):20170369. doi: 10.1259/dmfr.20170369. Epub 2018 Feb 13.

PMID:
29376745
12.

Solid State Sensor for Simultaneous Measurement of Total Alkalinity and pH of Seawater.

Briggs EM, Sandoval S, Erten A, Takeshita Y, Kummel AC, Martz TR.

ACS Sens. 2017 Sep 22;2(9):1302-1309. doi: 10.1021/acssensors.7b00305. Epub 2017 Aug 25.

PMID:
28805369
13.

Corrigendum to 'Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities'.

Takamura T, Kita Y, Nakagen M, Sakurai M, Isobe Y, Takeshita Y, Kawai K, Urabe T, Kaneko S.

Heliyon. 2017 Jul 26;3(7):e00363. doi: 10.1016/j.heliyon.2017.e00363. eCollection 2017 Jul.

14.

Cluster signal-to-noise analysis for evaluation of the information content in an image.

Weerawanich W, Shimizu M, Takeshita Y, Okamura K, Yoshida S, Yoshiura K.

Dentomaxillofac Radiol. 2018 Jan;47(1):20170147. doi: 10.1259/dmfr.20170147. Epub 2017 Dec 11.

PMID:
28749736
15.

Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities.

Takamura T, Kita Y, Nakagen M, Sakurai M, Isobe Y, Takeshita Y, Kawai K, Urabe T, Kaneko S.

Heliyon. 2017 Jul 4;3(7):e00347. doi: 10.1016/j.heliyon.2017.e00347. eCollection 2017 Jul. Erratum in: Heliyon. 2017 Jul 26;3(7):e00363.

16.

Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.

Shimizu F, Schaller KL, Owens GP, Cotleur AC, Kellner D, Takeshita Y, Obermeier B, Kryzer TJ, Sano Y, Kanda T, Lennon VA, Ransohoff RM, Bennett JL.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaai9111. doi: 10.1126/scitranslmed.aai9111.

17.

Anterior cage dislodgement in posterior lumbar interbody fusion: a review of 12 patients.

Murase S, Oshima Y, Takeshita Y, Miyoshi K, Soma K, Kawamura N, Kunogi J, Yamazaki T, Ariyoshi D, Sano S, Inanami H, Takeshita K, Tanaka S.

J Neurosurg Spine. 2017 Jul;27(1):48-55. doi: 10.3171/2016.12.SPINE16429. Epub 2017 May 5.

PMID:
28475020
18.

Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes.

Tajima-Shirasaki N, Ishii KA, Takayama H, Shirasaki T, Iwama H, Chikamoto K, Saito Y, Iwasaki Y, Teraguchi A, Lan F, Kikuchi A, Takeshita Y, Murao K, Matsugo S, Kaneko S, Misu H, Takamura T.

J Biol Chem. 2017 Jun 30;292(26):10791-10800. doi: 10.1074/jbc.M116.747006. Epub 2017 May 2.

19.

Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.

Ishihara T, Nogami K, Matsumoto T, Nomura A, Takeshita Y, Ochi S, Shima M.

Int J Hematol. 2017 Jul;106(1):126-134. doi: 10.1007/s12185-017-2213-5. Epub 2017 Mar 16.

PMID:
28303518
20.

Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle.

Misu H, Takayama H, Saito Y, Mita Y, Kikuchi A, Ishii KA, Chikamoto K, Kanamori T, Tajima N, Lan F, Takeshita Y, Honda M, Tanaka M, Kato S, Matsuyama N, Yoshioka Y, Iwayama K, Tokuyama K, Akazawa N, Maeda S, Takekoshi K, Matsugo S, Noguchi N, Kaneko S, Takamura T.

Nat Med. 2017 Apr;23(4):508-516. doi: 10.1038/nm.4295. Epub 2017 Feb 27.

PMID:
28263310
21.

Effects of exposure parameters and slice thickness on detecting clear and unclear mandibular canals using cone beam CT.

Jasa GR, Shimizu M, Okamura K, Tokumori K, Takeshita Y, Weerawanich W, Yoshiura K.

Dentomaxillofac Radiol. 2017 Apr;46(4):20160315. doi: 10.1259/dmfr.20160315. Epub 2017 Feb 17.

22.

Establishment of a new conditionally immortalized human skeletal muscle microvascular endothelial cell line.

Sano H, Sano Y, Ishiguchi E, Shimizu F, Omoto M, Maeda T, Nishihara H, Takeshita Y, Takahashi S, Oishi M, Kanda T.

J Cell Physiol. 2017 Dec;232(12):3286-3295. doi: 10.1002/jcp.25772. Epub 2017 Apr 18.

PMID:
28063233
23.

A new method to evaluate image quality of CBCT images quantitatively without observers.

Takeshita Y, Shimizu M, Okamura K, Yoshida S, Weerawanich W, Tokumori K, Jasa GR, Yoshiura K.

Dentomaxillofac Radiol. 2017 Mar;46(3):20160331. doi: 10.1259/dmfr.20160331. Epub 2017 Feb 17.

24.

Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.

Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E, Sano Y, Kryzer TJ, Lennon VA, Kanda T, Ransohoff RM.

Neurol Neuroimmunol Neuroinflamm. 2016 Dec 19;4(1):e311. doi: 10.1212/NXI.0000000000000311. eCollection 2017 Jan.

25.

Immunohistochemical analysis of huntingtin-associated protein 1 in adult rat spinal cord and its regional relationship with androgen receptor.

Islam MN, Takeshita Y, Yanai A, Imagawa A, Jahan MR, Wroblewski G, Nemoto J, Fujinaga R, Shinoda K.

Neuroscience. 2017 Jan 6;340:201-217. doi: 10.1016/j.neuroscience.2016.10.053. Epub 2016 Oct 29.

PMID:
27984179
26.

CK2 phospho-independent assembly of the Tel2-associated stress-signaling complexes in Schizosaccharomyces pombe.

Inoue H, Sugimoto S, Takeshita Y, Takeuchi M, Hatanaka M, Nagao K, Hayashi T, Kokubu A, Yanagida M, Kanoh J.

Genes Cells. 2017 Jan;22(1):59-70. doi: 10.1111/gtc.12454. Epub 2016 Dec 9.

27.

Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control study.

Takeshita Y, Shibata N, Kasanuki K, Nagata T, Shinagawa S, Kobayashi N, Ohnuma T, Suzuki A, Kawai E, Takayama T, Nishioka K, Motoi Y, Hattori N, Nakayama K, Yamada H, Arai H.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1241-1246. doi: 10.1002/gps.4600. Epub 2016 Oct 4.

PMID:
27699858
28.

Rapid response of the steatosis-sensing hepatokine LECT2 during diet-induced weight cycling in mice.

Chikamoto K, Misu H, Takayama H, Kikuchi A, Ishii KA, Lan F, Takata N, Tajima-Shirasaki N, Takeshita Y, Tsugane H, Kaneko S, Matsugo S, Takamura T.

Biochem Biophys Res Commun. 2016 Sep 23;478(3):1310-6. doi: 10.1016/j.bbrc.2016.08.117. Epub 2016 Aug 22.

29.

Altered gene expression in T-cell receptor signalling in peripheral blood leucocytes in acute coronary syndrome predicts secondary coronary events.

Takashima S, Usui S, Kurokawa K, Kitano T, Kato T, Murai H, Furusho H, Oda H, Maruyama M, Nagata Y, Usuda K, Kubota K, Takeshita Y, Sakai Y, Honda M, Kaneko S, Takamura M.

Open Heart. 2016 Jun 30;3(1):e000400. doi: 10.1136/openhrt-2016-000400. eCollection 2016.

30.

Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.

Nishihara H, Shimizu F, Kitagawa T, Yamanaka N, Akada J, Kuramitsu Y, Sano Y, Takeshita Y, Maeda T, Abe M, Koga M, Nakamura K, Kanda T.

Mult Scler. 2017 Mar;23(3):382-394. doi: 10.1177/1352458516655217. Epub 2016 Jul 11.

PMID:
27339072
31.

Fat-free mass and calf circumference as body composition indices to determine non-exercise activity thermogenesis in patients with diabetes.

Isobe Y, Sakurai M, Kita Y, Takeshita Y, Misu H, Kaneko S, Takamura T.

J Diabetes Investig. 2016 May;7(3):352-8. doi: 10.1111/jdi.12421. Epub 2015 Sep 22.

32.

Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.

Nagasawa K, Matsuura N, Takeshita Y, Ito S, Sano Y, Yamada Y, Uchinaka A, Murohara T, Nagata K.

Nutr Diabetes. 2016 Apr 25;6:e207. doi: 10.1038/nutd.2016.14.

33.

Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial.

Matsushima Y, Takeshita Y, Kita Y, Otoda T, Kato K, Toyama-Wakakuri H, Akahori H, Shimizu A, Hamaguchi E, Nishimura Y, Kanamori T, Kaneko S, Takamura T.

BMJ Open Diabetes Res Care. 2016 Apr 19;4(1):e000190. doi: 10.1136/bmjdrc-2015-000190. eCollection 2016.

34.

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.

Suzuki A, Shibata N, Kasanuki K, Nagata T, Shinagawa S, Kobayashi N, Ohnuma T, Takeshita Y, Kawai E, Takayama T, Nishioka K, Motoi Y, Hattori N, Nakayama K, Yamada H, Arai H.

Dement Geriatr Cogn Dis Extra. 2016 Mar 16;6(1):90-7. doi: 10.1159/000444080. eCollection 2016 Jan-Apr.

35.

Deep-Sea DuraFET: A Pressure Tolerant pH Sensor Designed for Global Sensor Networks.

Johnson KS, Jannasch HW, Coletti LJ, Elrod VA, Martz TR, Takeshita Y, Carlson RJ, Connery JG.

Anal Chem. 2016 Mar 15;88(6):3249-56. doi: 10.1021/acs.analchem.5b04653. Epub 2016 Mar 1.

PMID:
26890717
36.

Acoustic pressure reduction at rhythm deviants causes magnetoencephalographic response.

Takeshita Y, Yokosawa K.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6650-3. doi: 10.1109/EMBC.2015.7319918.

PMID:
26737818
37.

Bending of a vertical cannula without alarm during insulin pump therapy as a cause of unexpected hyperglycemia: A Japanese issue?

Kuroda K, Takeshita Y, Kaneko S, Takamura T.

J Diabetes Investig. 2015 Nov;6(6):739-40. doi: 10.1111/jdi.12357. Epub 2015 Oct 27. No abstract available.

38.

[A Case of Mitral Valvular Re-repair in a Patient with Hemolytic Anemia after Mitral Valvular Repair].

Tomino M, Miyata K, Takeshita Y, Kaneko K, Kanazawa H, Uchino H.

Masui. 2015 Jul;64(7):761-3. Japanese.

PMID:
26422945
39.

Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study.

Takeshita Y, Takamura T, Kita Y, Takazakura A, Kato K, Isobe Y, Kaneko S.

BMJ Open Diabetes Res Care. 2015 Aug 28;3(1):e000122. doi: 10.1136/bmjdrc-2015-000122. eCollection 2015.

40.

Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.

Shimizu M, Okamura K, Kise Y, Takeshita Y, Furuhashi H, Weerawanich W, Moriyama M, Ohyama Y, Furukawa S, Nakamura S, Yoshiura K.

Arthritis Res Ther. 2015 Aug 23;17:223. doi: 10.1186/s13075-015-0751-x.

41.

[The Blood-Brain Barrier (BBB) and in vitro BBB Models].

Takeshita Y, Kanda T.

Brain Nerve. 2015 Aug;67(8):1035-42. doi: 10.11477/mf.1416200250. Review. Japanese.

PMID:
26241364
42.

Erratum. Increased Insulin Sensitivity and Hypoinsulinemia in APS Knockout Mice. Diabetes 2003;52:2657-2665.

Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y, Nakaya Y, Bando Y, Izumi K, Moodie SA, Kajiura F, Matsumoto M, Takatsu K, Takaki S, Ebina Y.

Diabetes. 2015 Aug;64(8):3050. doi: 10.2337/db15-er08. No abstract available.

43.

Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?

Spampinato SF, Obermeier B, Cotleur A, Love A, Takeshita Y, Sano Y, Kanda T, Ransohoff RM.

PLoS One. 2015 Jul 21;10(7):e0133392. doi: 10.1371/journal.pone.0133392. eCollection 2015.

44.

Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.

Takeshita Y, Watanabe S, Hattori T, Nagasawa K, Matsuura N, Takahashi K, Murohara T, Nagata K.

Hypertens Res. 2015 Nov;38(11):741-50. doi: 10.1038/hr.2015.77. Epub 2015 Jul 9.

PMID:
26155752
45.

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy.

Takazakura A, Sakurai M, Bando Y, Misu H, Takeshita Y, Kita Y, Shimizu A, Hayakawa T, Kato K, Kaneko S, Takamura T.

J Diabetes Investig. 2015 May;6(3):346-53. doi: 10.1111/jdi.12296. Epub 2014 Nov 27.

46.

Comparison of the Japanese Orthopaedic Association (JOA) score and modified JOA (mJOA) score for the assessment of cervical myelopathy: a multicenter observational study.

Kato S, Oshima Y, Oka H, Chikuda H, Takeshita Y, Miyoshi K, Kawamura N, Masuda K, Kunogi J, Okazaki R, Azuma S, Hara N, Tanaka S, Takeshita K.

PLoS One. 2015 Apr 2;10(4):e0123022. doi: 10.1371/journal.pone.0123022. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128392.

47.

Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2).

Azushima K, Tamura K, Haku S, Wakui H, Kanaoka T, Ohsawa M, Uneda K, Kobayashi R, Ohki K, Dejima T, Maeda A, Hashimoto T, Oshikawa J, Kobayashi Y, Nomura K, Azushima C, Takeshita Y, Fujino R, Uchida K, Shibuya K, Ando D, Tokita Y, Fujikawa T, Toya Y, Umemura S.

Atherosclerosis. 2015 May;240(1):297-304. doi: 10.1016/j.atherosclerosis.2015.01.025. Epub 2015 Mar 25.

48.

Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.

Iwata H, Yamaguchi K, Takeshita Y, Kubota A, Hirakawa S, Isobe T, Hirano M, Kim EY.

Aquat Toxicol. 2015 May;162:138-151. doi: 10.1016/j.aquatox.2015.03.010. Epub 2015 Mar 11.

PMID:
25814058
49.

Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.

Shimizu F, Nishihara H, Sano Y, Takeshita Y, Takahashi S, Maeda T, Takahashi T, Abe M, Koga M, Kanda T.

PLoS One. 2015 Mar 26;10(3):e0122000. doi: 10.1371/journal.pone.0122000. eCollection 2015.

50.

Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study.

Takeshita Y, Takamura T, Kita Y, Otoda T, Kato K, Wakakuri H, Yamada M, Misu H, Matsushima Y, Kaneko S; Establishment of Rationale for Antiaging Diabetic Medicine (ERA-DM) Study Chapter 2 Group.

J Diabetes Investig. 2015 Mar;6(2):192-200. doi: 10.1111/jdi.12269. Epub 2014 Sep 9.

Supplemental Content

Loading ...
Support Center